INMODE LTD (INMD)
IL0011595993 - Common Stock
We assign a fundamental rating of 7 out of 10 to INMD. INMD was compared to 191 industry peers in the Health Care Equipment & Supplies industry. INMD gets an excellent profitability rating and is at the same time showing great financial health properties. INMD scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make INMD a good candidate for value investing.
1. Profitability
1.1 Basic Checks
INMD had positive earnings in the past year.
INMD had a positive operating cash flow in the past year.
INMD had positive earnings in each of the past 5 years.
Each year in the past 5 years INMD had a positive operating cash flow.
1.2 Ratios
INMD has a Return On Assets of 20.30%. This is amongst the best in the industry. INMD outperforms 97.91% of its industry peers.
INMD has a better Return On Equity (22.20%) than 94.76% of its industry peers.
Looking at the Return On Invested Capital, with a value of 17.89%, INMD belongs to the top of the industry, outperforming 97.91% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for INMD is significantly above the industry average of 8.62%.
The 3 year average ROIC (28.25%) for INMD is well above the current ROIC(17.89%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.3% | ||
| ROE | 22.2% | ||
| ROIC | 17.89% |
ROA(3y)27.49%
ROA(5y)27.16%
ROE(3y)31.31%
ROE(5y)31.63%
ROIC(3y)28.25%
ROIC(5y)27.22%
1.3 Margins
The Profit Margin of INMD (38.83%) is better than 99.48% of its industry peers.
In the last couple of years the Profit Margin of INMD has grown nicely.
The Operating Margin of INMD (37.05%) is better than 100.00% of its industry peers.
INMD's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 83.09%, INMD belongs to the top of the industry, outperforming 94.24% of the companies in the same industry.
In the last couple of years the Gross Margin of INMD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 37.05% | ||
| PM (TTM) | 38.83% | ||
| GM | 83.09% |
OM growth 3Y4.03%
OM growth 5Y4.81%
PM growth 3Y3.39%
PM growth 5Y12.47%
GM growth 3Y-0.57%
GM growth 5Y-0.32%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so INMD is creating value.
INMD has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, INMD has more shares outstanding
INMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
There is no outstanding debt for INMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.87
WACC9.55%
2.3 Liquidity
INMD has a Current Ratio of 13.45. This indicates that INMD is financially healthy and has no problem in meeting its short term obligations.
INMD has a Current ratio of 13.45. This is amongst the best in the industry. INMD outperforms 97.91% of its industry peers.
A Quick Ratio of 12.66 indicates that INMD has no problem at all paying its short term obligations.
INMD has a Quick ratio of 12.66. This is amongst the best in the industry. INMD outperforms 97.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 13.45 | ||
| Quick Ratio | 12.66 |
3. Growth
3.1 Past
INMD shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.45%.
Measured over the past years, INMD shows a very strong growth in Earnings Per Share. The EPS has been growing by 45.76% on average per year.
Looking at the last year, INMD shows a decrease in Revenue. The Revenue has decreased by -1.71% in the last year.
The Revenue has been growing by 37.48% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-7.45%
EPS 3Y34.38%
EPS 5Y45.76%
EPS Q2Q%-38.46%
Revenue 1Y (TTM)-1.71%
Revenue growth 3Y33.65%
Revenue growth 5Y37.48%
Sales Q2Q%-24.31%
3.2 Future
Based on estimates for the next years, INMD will show a decrease in Earnings Per Share. The EPS will decrease by -1.05% on average per year.
Based on estimates for the next years, INMD will show a small growth in Revenue. The Revenue will grow by 3.56% on average per year.
EPS Next Y-18.81%
EPS Next 2Y-4.94%
EPS Next 3Y-1.05%
EPS Next 5YN/A
Revenue Next Year-2.19%
Revenue Next 2Y2.7%
Revenue Next 3Y3.56%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 7.58, which indicates a rather cheap valuation of INMD.
Compared to the rest of the industry, the Price/Earnings ratio of INMD indicates a rather cheap valuation: INMD is cheaper than 98.43% of the companies listed in the same industry.
INMD is valuated cheaply when we compare the Price/Earnings ratio to 24.41, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 7.73, the valuation of INMD can be described as very cheap.
INMD's Price/Forward Earnings ratio is rather cheap when compared to the industry. INMD is cheaper than 99.48% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of INMD to the average of the S&P500 Index (20.59), we can say INMD is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.58 | ||
| Fwd PE | 7.73 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, INMD is valued cheaply inside the industry as 98.95% of the companies are valued more expensively.
INMD's Price/Free Cash Flow ratio is rather cheap when compared to the industry. INMD is cheaper than 98.95% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.44 | ||
| EV/EBITDA | 1.89 |
4.3 Compensation for Growth
INMD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.17
EPS Next 2Y-4.94%
EPS Next 3Y-1.05%
5. Dividend
5.1 Amount
No dividends for INMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
INMODE LTD
NASDAQ:INMD (7/26/2024, 3:46:01 PM)
After market: 17.95 +0.06 (+0.34%)17.89
+0.29 (+1.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.51B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.58 | ||
| Fwd PE | 7.73 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 20.3% | ||
| ROE | 22.2% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 37.05% | ||
| PM (TTM) | 38.83% | ||
| GM | 83.09% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 13.45 | ||
| Quick Ratio | 12.66 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-7.45%
EPS 3Y34.38%
EPS 5Y
EPS Q2Q%
EPS Next Y-18.81%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.71%
Revenue growth 3Y33.65%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y